<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0025">
 <label>25.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zeuzem</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Foster</surname>
    <given-names>GR</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>S</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection</article-title>. 
  <source>N Engl J Med</source>
  <year>2018</year>; 
  <volume>378</volume>:
  <fpage>354</fpage>â€“
  <lpage>69</lpage>.
  <pub-id pub-id-type="pmid">29365309</pub-id>
 </mixed-citation>
</ref>
